Health Canada authorizes one-shot COVID-19 vaccine from J & J

eAwaz Medicine

Ottawa – The first one-shot COVID-19 vaccine from Johnson & Johnson has been authorized by Health Canada, making it the fourth vaccine that can be administered to Canadians. Canada can now use the Pfizer-BioNTech, Moderna, AstraZeneca, and Johnson & Johnson vaccines in its ongoing mass vaccination campaign, largely viewed as a key pillar in overcoming the nearly year-long pandemic. Canada’s …

Interval between Oxford Covid doses can be extended to 3 months

eAwaz Medicine

London – The Lancet study reveals a three-month interval between doses of the Oxford University-AstraZeneca vaccine resulted in higher vaccine efficacy than a six-week interval. The findings from a phase 3 randomised controlled trial, showed the first dose offered 76 per cent protection in the three months between doses. , Researchers said this may allow countries to vaccinate a larger …

Health Canada, European Medicines Agency publish clinical data used to support authorizations of Moderna vaccine

eAwaz Medicine

Ottawa – Openness and transparency are key to building confidence in COVID-19 vaccines. Health Canada and the European Medicines Agency (EMA) collaboratively published the full clinical data reviewed as part of their authorizations of the Moderna COVID-19 vaccine. This international partnership highlights the shared commitment of both organizations to ensure the public has as much information as possible to make …

How to cure prostate cancer?

eAwaz Medicine

New York – A study, published in the ‘Journal of Clinical Investigation’, shows that targeting the enzyme MAPK4 in human prostate cancer might provide a novel therapeutic strategy for the disease. They concertedly activates androgen receptor (AR) and AKT, molecules at the core of two cellular signalling pathways known to promote prostate cancer growth and resistance to standard therapy. Researcher …

Treating endometrial cancer recurrence

eAwaz Medicine

New York – A team of researchers have found that endocrine-targeted therapies and an assessment of biomarkers in sex hormone and insulin signalling pathways can prevent and treat endometrial cancer recurrence. They said sex hormones and insulin growth factors are associated with recurrence risk of endometrial cancer — a type of uterine cancer that starts in inner lining of uterus. …

How to better control prosthetic limbs?

eAwaz Medicine

New York – Researchers at Massachusetts Institute of Technology (MIT) have invented a new type of amputation surgery to help amputees take better control of their muscles and understand if their phantom limb is in space. This, they said, should translate to better control of prosthetic limbs, as well as a reduction of limb pain. The MIT team whose study …

J&J’s Covid-19 Vaccine Is Safe and Effective: FDA

eAwaz Medicine

New Brunswick – The Food and Drug Administration has said Johnson & Johnson’s Covid-19 vaccine data indicate that it is overall safe and highly effective — 86 percent — against the most severe outcomes of the illness. It comes two days before a panel of independent FDA advisers are scheduled to discuss the company’s application for emergency use. It is …

Sanofi is developing two vaccine candidates

eAwaz Medicine

Paris – Sanofi has joined forces to develop two vaccine candidates to help prevent and control COVID-19. In December 2020, initial results from a phase 1/2 clinical trial showed an immune response comparable to patients who recovered from COVID-19 in adults aged 18 to 49 years, but a low immune response in older adults, likely due to an insufficient concentration …

Gene-based blood test to evaluate treatment progress

eAwaz Medicine

New York – A new study finds that a test monitoring DNA fragments blood levels released by dying tumour cells may serve as an accurate early indicator of treatment success in people in late stages of one of the most aggressive forms of skin cancer. Researchers looked at adults with undetectable levels of freely circulating tumour DNA (ctDNA) four weeks …

Canada Offers Funding for Emerging Variants Research

eAwaz Medicine

Ottawa – CIHR will launch a funding opportunity in the coming weeks to provide up to $9 million funding for a national network of networks focused on all four pillars of SARS-CoV-2 variant research. Specifically, up to $6M will support the establishment of a single CIHR Network for Emerging Variants Research and up to $3 million will enable the rapid …